This week, we unpack Hims & Hers introduction of discounted weight loss drugs and the impact these revolutionary pharmaceuticals have had on the broader market. Did you know Eli Lily developed the tech first and let their patent expire?

Join Mike and Anne Marie as they discuss the transformative impact of AI voice assistants, the surge of interest in Chinese stocks among top fund managers, and provide an exhaustingly detailed analysis of Red Lobster's bankruptcy saga.

This episode is sponsored by Vodafone Business. This week, Vodafone Business Ireland launches its new partnership with RingCentral, one of the leading providers of Cloud-based unified communications for remote and hybrid teams. If you’re a business owner in need of UCAS tools, Vodafone Business UC with RingCentral is here to help.

Learn more here.

Become a successful investor by checking out all the content MyWallSt has to offer:

📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7

💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/

🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/

🎉 Follow MyWallSt on social:

🐦 Twitter: @MyWallStHQ

💃 TikTok: @MyWallSt

📸 Instagram: @MyWallSt

🖥️ Facebook: @MyWallSt

👔 LinkedIn: MyWallSt

03:15 The Rise of Weight Loss Drugs

18:55 The Red Lobster Bankruptcy Saga

33:30 Wall Street's Bet on Chinese Stocks

37:40 The Scarlett Johansson and OpenAI Controversy

Hosted on Acast. See acast.com/privacy for more information.

#211 The Weight Loss Drug Revolution: The Hottest Trend on Wall Street

Stock Club